Analysts: Pacira Pharmaceuticals Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

33.73USD
10:48am EDT
Price Change (% chg)

$-0.38 (-1.11%)
Prev Close
$34.11
Open
$31.00
Day's High
$34.92
Day's Low
$30.75
Volume
126,571
Avg. Vol
116,882
52-wk High
$35.86
52-wk Low
$14.46

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.35 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.40 1.40 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 4 20.31 21.50 17.53 --
Quarter Ending Dec-13 4 24.72 26.90 21.47 --
Year Ending Dec-13 5 74.39 78.00 65.64 92.30
Year Ending Dec-14 5 138.12 157.40 80.00 190.94
Earnings (per share)
Quarter Ending Sep-13 5 -0.35 -0.29 -0.44 --
Quarter Ending Dec-13 5 -0.23 -0.17 -0.36 --
Year Ending Dec-13 5 -1.70 -1.55 -2.00 -0.29
Year Ending Dec-14 5 0.40 0.63 0.21 1.66

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 13.22 11.59 1.64 12.38
Quarter Ending Dec-12 9.83 10.45 0.62 6.29
Quarter Ending Sep-12 7.85 8.49 0.64 8.10
Quarter Ending Jun-12 8.77 12.34 3.57 40.77
Quarter Ending Mar-12 7.59 7.80 0.21 2.77

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 20.31 20.31 19.81 19.81 --
Quarter Ending Dec-13 24.72 24.72 24.72 24.72 --
Year Ending Dec-13 74.39 74.39 74.39 74.39 92.30
Year Ending Dec-14 138.12 138.12 138.12 138.12 190.94

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 1 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$460.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks